Neurofilament light chains (NF-L) and CXC motif chemokine ligand 13 (CXCL13) have been demonstrated to function as dependable biomarkers for both inflammatory processes and neurodegenerative changes in the context of MS. The gene discussed is CXCL13; the disease is myeloid sarcoma.